Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J]. J Am Coll Cardiol, 2013 Nov 7. [Epub ahead of print].Cholesterol Treatment Trialists' (CTT) Collaboration.Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170,000 participants in 26 randomised trials[J]. Lancet, 2010,376:1670-1681.他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识组. 他汀类药物防治缺血性卒中/短暂性脑缺血发作专家共识[J]. 中国卒中杂志, 2013, 8:565-575.Mckinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage:a meta-analysis of 31 randomized controlled trials[J]. Stroke, 2012, 43:2149-2156.CRESTOR (rosuvastatin calcium) tablets Prescribing Informat ion[EB/OL]. (2013- 08). ht t p://www1.astrazeneca-us.com/pi/crestor.pdf.6 Ch a n J, Ba o W, Fay y a d R, e t a l . Sa f e t y of atorvastatin in Asian patients within clinical trials.POSTER:GW23-e2689[R]. Beijing:the 23rd Great Wall International Congress of Cardiology, 2012.Hoffman KB, Kraus C, Dimbil M, et al. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class[J]. PLoS One. 2012,7:e42866.Riordan M. How Good Is the New ACC/AHA Risk Calculator?[EB/OL]. (2013-11-18). http://www.medscape.com/viewarticle/814579. |